In vivo imaging of brain lesions with [11C]CLINME, a new PET radioligand of peripheral benzodiazepine receptors
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
The peripheral benzodiazepine receptor (PBR) is expressed by microglial cells in many neuropathologies involving neuroinflammation. PK11195, the reference compound for PBR, is used for positron emission tomography (PET) imaging but has a limited capacity to quantify PBR expression. Here we describe the new PBR ligand CLINME as an alternative to PK11195. In vitro and in vivo imaging properties of [11 C]CLINME were studied in a rat model of local acute neuroinflammation, and compared with the reference compound [11 C]PK11195, using autoradiography and PET imaging. Immunohistochemistry study was performed to validate the imaging data. [11 C]CLINME exhibited a higher contrast between the PBR‐expressing lesion site and the intact side of the same rat brain than [11 C]PK11195 (2.14 ± 0.09 vs. 1.62 ± 0.05 fold increase, respectively). The difference was due to a lower uptake for [11 C]CLINME than for [11 C]PK11195 in the non‐inflammatory part of the brain in which PBR was not expressed, while uptake levels in the lesion were similar for both tracers. Tracer localization correlated well with that of activated microglial cells, demonstrated by immunohistochemistry and PBR expression detected by autoradiography. Modeling using the simplified tissue reference model showed that R1 was similar for both ligands (R1 ∼ 1), with [11 C]CLINME exhibiting a higher binding potential than [11 C]PK11195 (1.07 ± 0.30 vs. 0.66 ± 0.15). The results show that [11 C]CLINME performs better than [11 C]PK11195 in this model. Further studies of this new compound should be carried out to better define its capacity to overcome the limitations of [11 C]PK11195 for PBR PET imaging. © 2007 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
Gerhard, A., Pavese, N., Hotton, G., Turkheimer, F., Es, M., Hammers, A., Eggert, K., Oertel, W., Banati, R. B., & Brooks, D. J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.08.002 · Cited by 1,200 · cited 1×
“…brain tissue is [11C]PK11195 (Banati et al., 2000; Benavides et al., 1990; Bertram and Tanzi, 2005; Cagnin et al., 2001; Ferri et al., 2005; Gerhard et al., 2003, 2004, 2005, 2006; Groom et al., 1995; Kropholler et al., 2005; Lockhart et al., 2003; Pappata et al., 1991, 2000; Petit-Taboue…”
In-vivo measurement of activated microglia in dementia
Cagnin, A., Brooks, D. J., Kennedy, A. M., Gunn, R. N., Myers, R., Turkheimer, F. E., Jones, T., & Banati, R. B. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05625-2 · Cited by 1,054 · cited 1×
“…PET imaging of PBR expression in challenged brain tissue is [11C]PK11195 (Banati et al., 2000; Benavides et al., 1990; Bertram and Tanzi, 2005; Cagnin et al., 2001; Ferri et al., 2005; Gerhard et al., 2003, 2004, 2005, 2006; Groom et al., 1995; Kropholler et al., 2005; Lockhart et al., 2003;…”
BackgroundTurner, M. R., Cagnin, A., Turkheimer, F. E., Miller, C. C. J., Shaw, C. E., Brooks, D. J., Leigh, P. N., & Banati, R. B. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.012 · Cited by 737 · cited 1×
“…2000; Benavides et al., 1990; Bertram and Tanzi, 2005; Cagnin et al., 2001; Ferri et al., 2005; Gerhard et al., 2003, 2004, 2005, 2006; Groom et al., 1995; Kropholler et al., 2005; Lockhart et al., 2003; Pappata et al., 1991, 2000; Petit-Taboue et al., 1991; Tai et al., 2007; Turner et al., 2004).”
The role of inflammation in Alzheimer’s disease
Tuppo, E. E., & Arias, H. R. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.07.009 · Cited by 734 · cited 1×
“…2002; Hirsch et al., 2005; Jander and Stoll, 1998; Jander et al., 2002; Koistinaho and Koistinaho, 2005; Lindberg et al., 2005; Maier et al., 2001; Ouchi et al., 2005; Perini et al., 2001; Pinteaux et al., 2006; Rothwell et al., 1997; Stoll et al., 1998; Tuppo and Arias, 2005; Yu and Lau, 2000).”
BackgroundThe genetic epidemiology of neurodegenerative disease
Bertram, L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24761 · Cited by 680
The peripheral benzodiazepine binding site in the brain in multiple sclerosis
Banati, R. B., Newcombe, J., Gunn, R. N., Cagnin, A., Turkheimer, F., Heppner, F., Price, G., Wegner, F., Giovannoni, G., Miller, D. H., et al. (2000) · Brain · doi:10.1093/brain/123.11.2321 · Cited by 661
Microglial activation in presymptomatic Huntington's disease gene carriers
Tai, Y. F., Pavese, N., Gerhard, A., Tabrizi, S. J., Barker, R. A., Brooks, D. J., & Piccini, P. (2007) · Brain · doi:10.1093/brain/awm044 · Cited by 440 · cited 1×
“…2000; Benavides et al., 1990; Bertram and Tanzi, 2005; Cagnin et al., 2001; Ferri et al., 2005; Gerhard et al., 2003, 2004, 2005, 2006; Groom et al., 1995; Kropholler et al., 2005; Lockhart et al., 2003; Pappata et al., 1991, 2000; Petit-Taboue et al., 1991; Tai et al., 2007; Turner et al., 2004).”
Cited by
Translocator protein 18 kDa (TSPO): Molecular sensor of brain injury and repair
Chen, M.-K., & Guilarte, T. R. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.12.004 · Cited by 506
“…has recently been shown to perform better than [11C]-PK11195 in terms of specific to nonspecific ratio in vivo using small animal PET in a rat model with intra-striatal injection of AMPA (α-Amino-3-hydroxy-5-methylisoxazole-4propionic acid)(Boutin et al., 2007b).”
BackgroundNuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers
Chauveau, F., Boutin, H., Van Camp, N., Dollé, F., & Tavitian, B. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-0908-9 · Cited by 417
Self-citationThe 18 kDa Translocator Protein, Microglia and Neuroinflammation
Liu, G., Middleton, R. J., Hatty, C. R., Kam, W. W., Chan, R., Pham, T., Harrison‐Brown, M., Dodson, E., Veale, K., & Banati, R. B. (2014) · Brain Pathology · doi:10.1111/bpa.12196 · Cited by 211
“The imidazopyridines were the most successful; five of these radiotracers ([123I]-CLINDE, [123I]-CLINME, [11C]-CLINME, [18F]-PBR111 and [18F]-PBR102) have further been evaluated in several rodent animal models of disease (10, 11, 33, 113, 114, 160, 171) confirming that these radiotracers can image and measure activate…”
BackgroundDickens, A. M., Vainio, S., Marjamäki, P., Johansson, J., Lehtiniemi, P., Rokka, J., Rinne, J., Solin, O., Haaparanta-Solin, M., Jones, P. A., et al. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.125625 · Cited by 138
“The pathology is associated with considerable cell death (28), which could be considered a confound, and maximal activation of the microglia and astrocytes occurs after 7 d (26).”
BackgroundImaging of microglia in patients with neurodegenerative disorders
Politis, M. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00096 · Cited by 111
Metadata
- Authors
- Boutin, H., Chauveau, F., Thominiaux, C., Kuhnast, B., Grégoire, M., Jan, S., Trebossen, R., Dollé, F., Tavitian, B., Mattner, F., & Katsifis, A.
- Venue
- Glia
- Publisher
- Wiley
- Published
- 2007-08-06
- Volume
- 55
- Issue
- 14
- Pages
- 1459-1468
- ISSN
- 0894-1491 (ISSN-L)
- 1098-1136
- OpenAlex
- W1970340573
- Cited by
- 67
- References
- 7
- FWCI
- 3.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: In vivo imaging of brain lesions with [11C]CLINME, a new PET radioligand of peripheral benzodiazepine receptors. https://app.cochat.ai/papers/10.1002/glia.20562
- The paper
- Boutin, H., Chauveau, F., Thominiaux, C., Kuhnast, B., Grégoire, M., Jan, S., Trebossen, R., Dollé, F., Tavitian, B., Mattner, F., & Katsifis, A. (2007). In vivo imaging of brain lesions with [11C]CLINME, a new PET radioligand of peripheral benzodiazepine receptors. Glia. https://doi.org/10.1002/glia.20562
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.